Growth Metrics

Opus Genetics (IRD) EBIT Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.96%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -29.67%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -50.81%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.47%
7 Evaxion A 62.56 Bn 62.54 Bn - 16.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -12.10%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 55.96%
10 Opus Genetics 357.99 Mn 298.03 Mn - -32.82%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -32.82%
Dec 31, 2025 -32.66%
Sep 30, 2025 -22.35%
Jun 30, 2025 -21.72%
Mar 31, 2025 -15.12%
Dec 31, 2024 -83.55%
Sep 30, 2024 -23.69%
Jun 30, 2024 -5.28%
Mar 31, 2024 -14.12%
Dec 31, 2023 27.12%
Sep 30, 2023 74.11%
Jun 30, 2023 -62.24%
Mar 31, 2023 -30.88%
Dec 31, 2022 89.67%
Sep 30, 2022 -25.78%
Jun 30, 2022 -18.22%
Mar 31, 2022 -18.23%
Dec 31, 2021 -7.38%
Sep 30, 2021 3.33%
Jun 30, 2021 -12.58%
Mar 31, 2021 4.13%
Dec 31, 2020 -41.99%
Sep 30, 2020 22.71%
Jun 30, 2020 33.46%
Mar 31, 2020 11.56%
Dec 31, 2019 48.57%
Sep 30, 2019 15.03%
Jun 30, 2019 8.59%
Mar 31, 2019 6.80%
Dec 31, 2018 -4.38%
Sep 30, 2018 -0.18%
Jun 30, 2018 -1.24%
Mar 31, 2018 -10.04%
Dec 31, 2017 -8.33%
Sep 30, 2017 -10.33%
Jun 30, 2017 -6.88%
Mar 31, 2017 -12.64%
Dec 31, 2016 -18.88%
Sep 30, 2016 -26.79%
Jun 30, 2016 -26.93%
Mar 31, 2016 -36.58%
Dec 31, 2015 -60.99%
Sep 30, 2015 -37.30%
Jun 30, 2015 -37.63%
Mar 31, 2015 -32.85%
Dec 31, 2014 -17.02%
Sep 30, 2014 2.17%
Jun 30, 2014 18.40%
Mar 31, 2014 10.92%
Dec 31, 2013 9.59%
Sep 30, 2013 8.33%
Jun 30, 2013 15.65%